Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

REN-1654 in Post-Herpetic Neuralgia: a Multi-Center, Placebo Controlled, 3-week Dose-Finding Study, With a 3-Week Active-Treatment Extension

NCT00099528 is registered in ClinicalTrials.gov with Renovis as lead sponsor.

NCT NCT00099528
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00099528 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
REN-1654 in Post-Herpetic Neuralgia: a Multi-Center, Placebo Controlled, 3-week Dose-Finding Study, With a 3-Week Active-Treatment Extension
Lead sponsor
Renovis
Phase
Phase 2
Overall status
Unknown status
Start date
August 31, 2003
Completion date
December 31, 2004
Enrollment
90
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

neuralgia, peripheral nervous system disease, shingles